Nuclear Medicine: Page 104

Novel PET tracer helps diagnose concussed patients

By Wayne Forrest

A new PET tracer, F-18 T807, has shown efficacy for diagnosing concussion-related brain degeneration for the first time in a live subject, according to a proof-of-concept study published online September 27 in Translational Psychiatry.

September 27, 2016

Most hospitals follow pediatric nuclear medicine dose guidelines

By Wayne Forrest

A survey of more than 80 general hospitals that perform nuclear medicine scans on pediatric patients shows the vast majority adhere to radiation-reducing protocols promoted by Image Gently and the 2010 North American guidelines, according to research published in the September issue of the Journal of Nuclear Medicine.

September 27, 2016

FluoroPharma offers new study on CardioPET

By AuntMinnie.com staff writers

FluoroPharma Medical said that a phase II trial concluded that its CardioPET radiopharmaceutical had significantly better image quality than SPECT and produced comparable diagnostic performance for coronary artery disease.

September 26, 2016

Navidea taps Goldberg as CEO

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has named chairman Dr. Michael Goldberg as president and CEO.

September 26, 2016

ASTRO: Negative PET/CT doesn't always mean dormant NSCLC

By Wayne Forrest

BOSTON - Certain non-small cell lung cancer (NSCLC) patients with clinical stage T2 tumors may still need their disease staged invasively, even if they have a negative PET/CT scan, according to a study presented on Sunday at the American Society for Radiation Oncology (ASTRO) meeting.

September 26, 2016

Lantheus touts clinical results for cardiac PET agent

By AuntMinnie.com staff writers

Lantheus Holdings is highlighting new data showing that its investigational flurpiridaz F-18 PET radiopharmaceutical agent for myocardial perfusion imaging (MPI) is superior to MPI with SPECT in patients with suspected heart disease undergoing stress testing.

September 22, 2016

Navidea gets $1M for 2 Lymphoseek milestones

By AuntMinnie.com staff writers

Navidea Biopharmaceuticals will receive payments totaling $1 million for fulfilling two commercial milestones for its Lymphoseek radiopharmaceutical.

September 21, 2016

Bruker to buy Oncovision's preclinical business

By AuntMinnie.com staff writers

Bruker said it has signed an agreement to acquire the preclinical imaging business of Spanish medical technology developer Oncovision. Terms of the transaction were not disclosed.

September 14, 2016

Report warns of shortages to Mo-99 supply in U.S.

By Wayne Forrest

Supplies of a key radioisotope used in nuclear cardiology scans could be disrupted next month when a Canadian nuclear reactor begins shutting down. U.S. healthcare providers could be left scrambling for new sources of molybdenum-99 (Mo-99) until other suppliers are able to step in and fill the void.

September 12, 2016

UAE steps up campaign on dose awareness

By Frances Rylands-Monk

Moves to limit medical radiation exposure are intensifying in the United Arab Emirates (UAE), and safety issues and education now are high on the agenda of healthcare professionals. Every effort must be made to reduce exposure and boost risk awareness, according to key participants at next month's summit in the region.

September 12, 2016

NorthStar hires 2 new VPs

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has hired two new vice presidents: James Brodack, PhD, will become vice president of regulatory affairs/quality assurance and Rim Milunas will become vice president of engineering.

September 11, 2016

Lantheus to sell 5M shares of stock

By AuntMinnie.com staff writers

Lantheus Holdings said it plans to sell 5.2 million shares of common stock in a public offering.

September 11, 2016

Previous Page

Page 104 of 438

Next Page